In addition, PKCα expression level correlates with estrogen receptor/progesterone receptor-negativity, higher tumor grade, increased Ki-67 positivity, and poor prognosis in human breast cancer [74], and the metastasis inhibitor KiSS1 may function in part by downregulating PKCα [75]. The gene discussed is PRKCA; the disease is breast cancer.